MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BYVOET, P.
Right arrow Articles by GOTTI, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by BYVOET, P.
Right arrow Articles by GOTTI, A.

Molecular Pharmacology, Vol 3, 142-152, Copyright © 1967 by the American Society for Pharmacology and Experimental Therapeutics

Isolation and Properties of Carbonic Anhydrase from Dog Kidney and Erythrocytes

PAUL BYVOET 1 and AIJA GOTTI 1

1 Department of Pharmacology and Therapeutics, University of Florida College of Medicine, Gainesville, Florida 32601

DEAE-cellulose chromatography of dog red cell carbonic anhydrase (CA) yielded a single main fraction, whereas under identical conditions human CA showed two distinct activity peaks corresponding with types B and C. When subjected to zone electrophoresis at pH 9.0 or 6.0, the main dog CA fraction moved as a single band with the same mobility as human CA type B. Its Km was found to be approximately 30 mM CO2 at 0°, 50% inhibitory concentrations for acetazolamide and sulfanilamide were similar to those of human CA type C. Structurally the enzyme appeared to be similar to other mammalian CA varieties. Preliminary experiments with CA obtained from the cytoplasmic fraction of dog kidney showed this enzyme to be similar to the red cell enzyme with respect to electrophoretic mobility and inhibition kinetics.

Note:
ACKNOWLEDGMENTS The authors wish to thank Dr. T. H. Maren for his interest and helpful suggestions. They also acknowledge the excellent assistance of Dr. T. K. McClane, Miss C. E. Wiley, Mr. A. C. Ellison, Mr. R. G. Schaffter, and Mr. R. Stern in various phases of this work. This research was supported by NIH grants CA 18402 and NB 01297.

Submitted on October 3, 1966







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1967 by the American Society for Pharmacology and Experimental Therapeutics